Indication
Vaginal Disease
1 clinical trial
1 product
Product
LABTHERA-001Clinical trial
Phase 1 Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Multiple Ascending Dose Clinical Trial to Evaluate the Safety, Tolerability and Acceptability of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Female VolunteersStatus: Recruiting, Estimated PCD: 2023-04-01